Semax 10mg

Here's the full description for Semax 10mg:

Semax | Synthetic Heptapeptide 10mg — ACTH-Derived Nootropic Research Compound For In Vitro Research Use Only — Not for Human or Veterinary Use

Overview:

Semax 10mg is a premier, research-grade synthetic heptapeptide compound representing one of the most scientifically fascinating and neurologically significant peptide research tools available in the contemporary laboratory science landscape. As a stabilized synthetic analogue derived from the N-terminal fragment of Adrenocorticotropic Hormone (ACTH 4-7) — extended with the additional tripeptide sequence Pro-Gly-Pro to enhance biological stability and research activity — Semax occupies a uniquely compelling position at the intersection of neuropeptide biology, cognitive neuroscience, and neurological research, consistently generating extraordinary scientific interest from researchers investigating the fundamental mechanisms of neurological function, neuroprotection, and cognitive biology.

Originally developed in the 1980s by the Institute of Molecular Genetics of the Russian Academy of Sciences as part of an ambitious scientific program aimed at creating stable, biologically active analogues of ACTH-derived peptides, Semax has since accumulated an impressive and continuously expanding body of scientific literature documenting its remarkable range of neurobiological research activities. Its unique structural design — combining the core biological activity sequence of ACTH 4-7 with the stabilizing Pro-Gly-Pro tripeptide extension — results in a research compound of exceptional neurological relevance, biological stability, and scientific versatility that has firmly established it as one of the most important and widely studied neuropeptide research compounds currently available to the modern laboratory researcher.

The 10mg variant of Semax offered by Mile High Compounds is precision-formulated as a lyophilized powder of the highest research-grade purity, providing research teams with an ideal compound volume for structured neurobiological investigations, controlled in vitro experimental protocols, and comprehensive neuropeptide research programs that demand consistent compound availability, exceptional dosing precision, and the highest standards of experimental reproducibility. Its well-characterized solubility in sterile water and research-compatible buffers ensures reliable and straightforward reconstitution for all standard laboratory research applications.

What makes Semax particularly extraordinary as a neurobiological research compound is the remarkable breadth and neurological specificity of its documented research activity profile. Unlike many neuropeptide research compounds that demonstrate relatively narrow biological specificity, Semax has been demonstrated in research settings to engage and influence multiple interconnected neurological systems simultaneously — including BDNF (Brain-Derived Neurotrophic Factor) signaling pathways, dopaminergic and serotonergic neurotransmitter systems, neuroinflammatory regulatory mechanisms, and neuroprotective gene expression networks — making it an extraordinarily powerful and multi-dimensional research tool for scientists investigating the complex molecular landscape of neurological biology, cognitive function, and neuroprotective signaling at the most fundamental cellular and molecular level.

Research Applications:

Semax 10mg supports an exceptionally broad and scientifically rich range of cutting-edge research applications spanning neuroscience, cognitive biology, neuroprotection research, neuroinflammation science, and molecular neurobiology, including:

• BDNF Signaling & Neurotrophic Factor Research — conducting comprehensive investigations into Semax's well-documented influence on Brain-Derived Neurotrophic Factor expression and signaling, examining how heptapeptide-mediated BDNF upregulation influences TrkB receptor activation, downstream MAPK and PI3K/Akt signaling cascades, synaptic plasticity regulation, neuronal survival signaling, and the broader neurotrophic support networks governing neurological cell health and functional integrity in controlled in vitro research models

• Dopaminergic & Serotonergic Neurotransmitter Research — examining Semax's documented influence on dopaminergic and serotonergic neurotransmitter system dynamics, investigating how ACTH-derived heptapeptide signaling modulates dopamine and serotonin receptor expression, neurotransmitter synthesis regulation, reuptake transporter activity, and the downstream consequences of altered monoaminergic signaling on neurological cell biology and function in laboratory research settings

• Neuroprotective Signaling & Cellular Resilience Research — studying Semax's well-documented neuroprotective research profile, investigating the molecular mechanisms through which ACTH 4-7 derived heptapeptide signaling activates cellular protective pathways, promotes neuronal survival under conditions of metabolic and oxidative stress, modulates apoptotic signaling cascades, and supports the maintenance of neurological cell integrity in controlled experimental research frameworks

• Cognitive Biology & Synaptic Plasticity Research — exploring Semax's extensively documented influence on cognitive biology research models, examining how heptapeptide-mediated neurotrophic factor upregulation, neurotransmitter system modulation, and synaptic protein expression regulation collectively influence the molecular determinants of synaptic plasticity, long-term potentiation mechanisms, and the fundamental cellular processes underlying learning and memory biology in laboratory research settings

• Neuroinflammation & Inflammatory Pathway Research — conducting detailed investigations into Semax's influence on neuroinflammatory signaling networks, examining its modulation of microglial activation states, pro-inflammatory cytokine expression including TNF-α, IL-1β, and IL-6, NF-κB pathway activity, and the molecular mechanisms through which ACTH-derived heptapeptide signaling regulates inflammatory processes within the central nervous system research environment

• Oxidative Stress & Antioxidant Defense Research — studying Semax's influence on neuronal antioxidant defense mechanisms, examining its effects on superoxide dismutase and catalase expression, reactive oxygen species management, mitochondrial membrane potential maintenance, and the broader cellular antioxidant signaling networks that protect neurological cells from oxidative damage in controlled laboratory research models

• Cerebrovascular Biology & Ischemia Research — investigating Semax's documented influence on cerebrovascular biology, examining its effects on cerebral blood flow regulation, endothelial cell function, blood-brain barrier integrity maintenance, and the molecular mechanisms governing neurological tissue responses to ischemic and hypoxic conditions in controlled in vitro research frameworks

• Neurogenesis & Neural Stem Cell Biology Research — exploring the scientific research interest in Semax's potential influence on neural stem cell proliferation, neuronal differentiation pathways, and the cellular mechanisms governing neurogenesis and neural circuit development in laboratory research models, examining how BDNF-mediated neurotrophic signaling contributes to neural progenitor cell biology

• Stress Response & HPA Axis Research — examining Semax's origins as an ACTH-derived peptide and its influence on hypothalamic-pituitary-adrenal axis signaling, stress response pathway regulation, glucocorticoid receptor biology, and the complex neuroendocrine mechanisms governing the cellular and molecular responses to physiological and psychological stress in neurobiological research models

• Receptor Binding & Neuropeptide Pharmacology Research — conducting detailed receptor binding studies, pharmacokinetic characterization experiments, and structure-activity relationship investigations to advance the scientific understanding of Semax's interaction dynamics with ACTH receptors, melanocortin receptor subtypes, and other relevant neurobiological receptor systems at the molecular and cellular level

• Comparative Neuropeptide Research — utilizing Semax alongside complementary neuropeptide research compounds such as Selank, Dihexa, and PE-22-28 in comparative laboratory research frameworks designed to map the broader landscape of synthetic neuropeptide biology, examining the relative contributions of different peptide signaling mechanisms to neurological function, neuroprotection, and cognitive biology research outcomes

• Gene Expression & Neurological Pathway Mapping Research — leveraging Semax's well-documented influence on neurological gene expression networks to conduct comprehensive pathway mapping investigations, examining how ACTH-derived heptapeptide signaling influences the transcriptional regulation of neurotrophic, neuroprotective, and neuroinflammatory gene networks in controlled in vitro neurobiological research models

Specifications:

Intended Use: This compound is intended exclusively for in vitro research applications. It is not to be used for human or animal administration, nor in any drug, food, cosmetic, or diagnostic product.

Legal Disclaimer: The information provided has not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease or condition. It is intended solely for use by qualified professionals in licensed laboratory environments.

Terms of Sale: By purchasing from Mile High Compounds, the buyer certifies that they are a qualified researcher and assumes full responsibility for proper handling, usage, and regulatory compliance. All sales are final.